SCHEMBL24267192

SCHEMBL24267192

C=CC(=C)CN[C@H]1C(C)(C)[C@H](Oc2ccc(C#N)c(Cl)c2)C1(C)C

nearest known ligand 0.60

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ AR P10275 19/20 0.60
▸ PGR P06401 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24267014 0.87 AR (0.62) ARPGR
SCHEMBL26216513 0.85 AR (0.65) ARPGR
SCHEMBL21744215 0.82 AR (0.67) ARPGR
SCHEMBL21744214 0.82 AR (0.67) ARPGR
SCHEMBL22565951 0.82 AR (0.56) ARPGR
SCHEMBL19599895 0.78 AR (0.71) ARPGR
SCHEMBL19599632 0.78 AR (0.71) ARPGR
SCHEMBL19599896 0.78 AR (0.71) ARPGR
SCHEMBL27014990 0.78 AR (0.71) ARPGR
SCHEMBL17941144 0.76 AR (0.84) AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3957633-A1 A CLASS OF BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUNDS FOR TARGETED DEGRADATION OF ANDROGEN RECEPTORS AND USE THEREOF Hinova Pharmaceuticals Inc. (CN) 2022-02-23 — — EP disclosed
Send feedback